CLASS II Device recall · Reported 25 Oct 2017 · FDA Enforcement Report

Xpert EV Assay recalled by Cepheid

Cepheid is recalling Xpert EV Assay. The recall was initiated on 15 Sep 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesbatch 1000045409 (lot 06802)
Quantity recalled977 kits (9770 units)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0028-2018
FDA event ID
78177
Recalling firm
Cepheid, Sunnyvale, CA
Classification
Class II
Status
Terminated
Recall initiated
15 Sep 2017
FDA classified
18 Oct 2017
Reported
25 Oct 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Device type
Spinal Implants

Timeline

15 Sep 2017Recall initiated by company
18 Oct 2017Classified by FDA+33 days
25 Oct 2017Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Customers have reported a higher than expected number of invalid test results when using the recalled product per the package insert.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Xpert EV Assay, Catalog GXEV-100N-10. The Cepheid Xpert EV assay is a reverse transcription polymerase chain reaction (RT-PCR) using the GeneXpert Dx System for the presumptive qualitative detection of enterovirus (EV) RNA in cerebrospinal fluid (CSF) specimens from individuals with signs and symptoms of meningitis.

Where it was distributed

USA, Austria, Australia, Belgium, Brazil, Canada, Chile, Colombia, Germany, Spain, France, UK, Ireland, Israel, Italy, South Korea, Lebanon, Netherlands, Philippines, Saudi Arabia, Sweden, Uruguay

Questions about this recall

Why was it recalled?

Customers have reported a higher than expected number of invalid test results when using the recalled product per the package insert.

Which lots are affected?

batch 1000045409 (lot 06802)

Where was it sold?

USA, Austria, Australia, Belgium, Brazil, Canada, Chile, Colombia, Germany, Spain, France, UK, Ireland, Israel, Italy, South Korea, Lebanon, Netherlands, Philippines, Saudi Arabia, Sweden, Uruguay

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cepheid

All 12

Other Spinal Implants recalls

All 1,159